HORMONE SENSITIVE PROSTATE CANCER
Clinical trials for HORMONE SENSITIVE PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new HORMONE SENSITIVE PROSTATE CANCER trials appear
Sign up with your email to follow new studies for HORMONE SENSITIVE PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New prostate cancer combo aims to delay disease worsening
Disease control Recruiting nowThis study tests whether adding the experimental drug mevrometostat to the standard treatment enzalutamide can slow down cancer growth better than enzalutamide alone. It involves 1000 men with metastatic prostate cancer that still responds to hormone therapy. Participants will be…
Matched conditions: HORMONE SENSITIVE PROSTATE CANCER
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Precision radiation targets hidden prostate cancer spots
Disease control Recruiting nowThis study tests whether giving radiation to the para-aortic lymph nodes (located in the abdomen) can better control prostate cancer that has returned in a limited number of spots. Men with hormone-sensitive prostate cancer and up to five lesions seen on a PSMA PET/CT scan will r…
Matched conditions: HORMONE SENSITIVE PROSTATE CANCER
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Precision radiation aims to stall prostate cancer spread
Disease control Recruiting nowThis study tests whether adding precise, high-dose radiation (SBRT) to standard hormone therapy can delay cancer progression in men with prostate cancer that has spread to 1-3 spots. About 118 participants will be randomly assigned to get SBRT plus standard care or standard care …
Matched conditions: HORMONE SENSITIVE PROSTATE CANCER
Phase: NA • Sponsor: Karin Soderkvist • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC